Chediak-Higashi syndrome in accelerated phase masquerading as severe acute malnutrition

Sunil Karande1, Shruti Agarwal, Bhaumik Gandhi

  • 1Department of Pediatrics, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.

BMJ Case Reports
|April 2, 2014
PubMed

Insights

Chediak-Higashi syndrome (CHS) is a rare genetic disorder characterized by impaired lysosome-trafficking. This case highlights CHS presenting with severe malnutrition and hemophagocytic lymphohistiocytosis, emphasizing the need for early diagnosis and treatment.

Area of Science:

  • Pediatrics
  • Genetics
  • Hematology

Background:

  • Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disorder.
  • It is characterized by mutations in the LYST gene, leading to impaired lysosomal trafficking.
  • Clinical manifestations include partial oculocutaneous albinism, recurrent infections, and progressive neurological dysfunction.

Purpose of the Study:

  • To report a case of Chediak-Higashi syndrome (CHS) in a toddler presenting with severe acute malnutrition.
  • To highlight the diagnostic challenges and clinical features of CHS.
  • To emphasize the association of CHS with hemophagocytic lymphohistiocytosis (HLH).

Main Methods:

  • Clinical presentation and anthropometric measurements.
  • Laboratory investigations including peripheral blood smear and bone marrow aspirate.
  • Hair microscopy for melanin granule assessment.

Main Results:

  • The patient presented with poor appetite, weight loss, recurrent infections, pallor, and edema, indicative of severe acute malnutrition.
  • Physical examination revealed hypopigmented hair and skin, splenohepatomegaly, pancytopenia, and hypoalbuminemia.
  • Microscopic examination of hair and bone marrow revealed characteristic large intracytoplasmic granules, confirming the diagnosis of CHS.
  • Coexistent hemophagocytic lymphohistiocytosis (HLH) was identified, indicating CHS in the accelerated phase.

Conclusions:

  • This case underscores the importance of considering CHS in children with unexplained hypopigmentation, recurrent infections, and cytopenias, even in the presence of severe malnutrition.
  • Early diagnosis and prompt initiation of treatment, including hematopoietic stem cell transplantation, are crucial for improving outcomes in CHS.
  • The accelerated phase of CHS, often associated with HLH, carries a poor prognosis if left untreated.

Related Concept Videos

Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide...
45
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
2.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K